Ofatumumab - Multiple sclerosis

You are here : Home > Formulary Search > Ofatumumab - Multiple sclerosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Subcutaneous injection (sc)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

NHSE

NICE

SPC

Restrictions / Comments :

Important

ASPH are the only Surrey Heartlands Trust commissioned to provide this.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Ofatumumab

Indication :

Multiple sclerosis

Group Name :

Keywords :

Brand Names Include :

Kesimpta

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Committee Recommendations (1)

02 Apr 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Ofatumumab is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Multiple sclerosis.